| BH | Balancer-heterozygous individuals |
| DXR | Doxorubicin |
| LD | Lethal Dose |
| ETT | Epithelial tumor test |
| FM | Frequency of mutation |
| FR | Frequency of recombination |
| HB | High Bioactivation cross |
| LATS1 | Large tumor suppressor kinase 1 |
| MH | Trans-heterozygous individuals |
| MTT | 3-(4,5-dimethylthiazol2-yl)-2,5-diphenyltetrazolium bromide |
| PCa | Prostate Cancer |
| ROS | Reactive oxygen species |
| SI | Selectivity Index |
| SMART | Somatic Mutation and Recombination Test |
| SMN | Subsequent malignant neoplasm |
| ST | Standard cross |
| TX | Toxicity Test |